Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen

Evidence-based pain therapy should rely on precisely defined and personalized criteria. This includes balancing the benefits and risks not only of single drugs but often requires complex between-drug comparisons. Non-steroidal anti-inflammatory drugs (NSAIDs) have been available for several decades...

Descripción completa

Detalles Bibliográficos
Autores principales: Farkouh, André, Hemetsberger, Margit, Noe, Christian R., Baumgärtel, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609416/
https://www.ncbi.nlm.nih.gov/pubmed/36297674
http://dx.doi.org/10.3390/pharmaceutics14102240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609416/
https://www.ncbi.nlm.nih.gov/pubmed/36297674
http://dx.doi.org/10.3390/pharmaceutics14102240

Ejemplares similares